GGrantIndex
Sort

48,018 grants matching immunotherapy

Technology/Map Endothelial Targets/Human Renal Tumors

$695,086
Jan E Schnitzer · Sidney Kimmel Cancer Center · R33 · FY2007 · CA

Mechanisms of function and targeting for complexes relevant to cancer biology

$695,079
Kylie Walters · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

The Evaluation of Novel Therapeutics for Genitourinary Malignancies

$695,031
William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA

[18F]F-AraG as an imaging biomarker for early diagnosis and monitoring of cardiotoxicity related to doxorubicin and immune check point inhibitor therapy

$694,766
Youngho Seo · University Of California, San Francisco · R01 · FY2023 · HL

The impact of interstitial fluid flow on CAR T cell trafficking, distribution, and efficacy

$694,724
Jennifer M Munson · Virginia Polytechnic Inst And St Univ · R01 · FY2021 · NS

MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM

$694,705
Mount Sinai Medical Center (Miami Beach) · U10 · FY2002 · CA

Quantifying the fitness cost of HIV-1 resistance to broadly neutralizing antibodies

$694,664
Rebecca Marie Lynch · George Washington University · R01 · FY2023 · AI

Structure-guided and epitope-based design of potent and broadly neutralizing nanobodies for COVID-19 mucosal immunotherapy

$694,551
Lisa A. Cavacini · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · AI

Immune Response to RBC Antigens

$694,350
Krystalyn E Hudson · Columbia University Health Sciences · R01 · FY2024 · HL

Using MRI and circulating tumor DNA to improve the interpretation of response to immunotherapy and targeted therapy in CNS metastases

$694,319
Elizabeth Gerstner · Massachusetts General Hospital · R01 · FY2021 · CA

T cell homeostasis

$694,309
Stephen C Jameson · University Of Minnesota · R01 · FY2019 · AI

Early interventions at ART initiation to reduce the HIV-1 reservoir and enhance adaptive immune responses

$694,301
Michael R Betts · University Of Pennsylvania · R01 · FY2024 · AI

Structure-guided and epitope-based design of potent and broadly neutralizing nanobodies for COVID-19 mucosal immunotherapy

$694,299
Yang Wang · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · AI

Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity

$694,227
Sharon S Evans · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA

Microglia replacement using engineered HSCs for treatment of leukodystrophies

$694,134
Frederick Bennett · University Of Pennsylvania · R01 · FY2025 · NS

Psycho-Spiritual Management for Patients with Advanced Cancer and their Family Caregivers

$694,107
Kathrin Milbury · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA

Targeting complement to enhance antitumor immunity and control malignant effusions in patients with recurrent epithelial ovarian cancer

$693,903
Emese Zsiros · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA

Targeting the tumor microenvironment with engineered CD4+ T cells

$693,880
Joshua R Veatch · Fred Hutchinson Cancer Center · R37 · FY2025 · CA

Targeting the tumor microenvironment with engineered CD4+ T cells

$693,880
Joshua R Veatch · Fred Hutchinson Cancer Center · R37 · FY2024 · CA

Adoptive T-cell Therapies Targeting Mutations in Hematologic Malignancies

$693,831
James Kochenderfer · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Clinical translation of a PD-L1 PET tracer to optimize immune checkpoint therapy in patients with non-small cell lung cancers

$693,779
Sridhar Nimmagadda · Johns Hopkins University · R01 · FY2025 · CA

Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy

$693,716
Sonia Sharma · La Jolla Institute For Immunology · R01 · FY2025 · CA

Investigating disseminated cancer cell clonal cooperation and immune control in dormancy and metastasis

$693,712
Julio A Aguirre-Ghiso · Albert Einstein College Of Medicine · U01 · FY2025 · CA

Prostate Cancer Immunotherapy

$693,642
Robert B Darnell · Rockefeller University · R01 · FY2006 · CA

ISOLATION AND DISTRIBUTION OF HIGH QUALITY HUMAN PANCREATIC ISLETS

$693,572
Ali Naji · University Of Pennsylvania · U42 · FY2007 · RR